| Product Code: ETC9616492 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market - Industry Life Cycle |
3.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market - Porter's Five Forces |
3.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and precision healthcare in Taiwan. |
4.2.2 Growing prevalence of chronic diseases requiring advanced diagnostic solutions. |
4.2.3 Technological advancements in next-generation sequencing (NGS) technology, making it more affordable and accessible. |
4.3 Market Restraints |
4.3.1 High initial setup and operating costs associated with NGS testing facilities. |
4.3.2 Regulatory challenges and stringent approval processes for NGS testing. |
4.3.3 Limited awareness and adoption of NGS testing among healthcare providers and patients in Taiwan. |
5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Trends |
6 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market, By Types |
6.1 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing By Synthesis, 2021- 2031F |
6.1.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Ion Semiconductor Sequencing, 2021- 2031F |
6.1.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single-Molecule Real-time Sequencing, 2021- 2031F |
6.1.6 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Nano Pore Sequencing, 2021- 2031F |
6.1.7 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F |
6.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.2.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Agricultural and Animal Research, 2021- 2031F |
6.2.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Academic Institutes and Research Centres, 2021- 2031F |
6.3.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market, By Service |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Human Genome Sequencing, 2021- 2031F |
6.4.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single Cell Sequencing, 2021- 2031F |
6.4.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Microbial Genome-based Sequencing, 2021- 2031F |
6.4.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Gene Regulation Services, 2021- 2031F |
6.4.6 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Animal and Plant Sequencing, 2021- 2031F |
6.4.7 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Services, 2021- 2031F |
6.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market, By Workflow |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.5.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.5.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Data Analysis, 2021- 2031F |
7 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Import-Export Trade Statistics |
7.1 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Export to Major Countries |
7.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Imports from Major Countries |
8 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Key Performance Indicators |
8.1 Average turnaround time for NGS test results. |
8.2 Rate of adoption of NGS testing by healthcare facilities in Taiwan. |
8.3 Number of partnerships and collaborations between NGS technology providers and healthcare institutions in Taiwan. |
9 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market - Opportunity Assessment |
9.1 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Service, 2021 & 2031F |
9.5 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market - Competitive Landscape |
10.1 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Clinical Next-Generation Sequencing (NSG) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here